GeneDx Holdings (WGS) Net Income towards Common Stockholders (2020 - 2025)
Historic Net Income towards Common Stockholders for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$7.6 million.
- GeneDx Holdings' Net Income towards Common Stockholders rose 814.49% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10249.55%. This contributed to the annual value of -$52.3 million for FY2024, which is 7025.27% up from last year.
- Per GeneDx Holdings' latest filing, its Net Income towards Common Stockholders stood at -$7.6 million for Q3 2025, which was up 814.49% from $10.8 million recorded in Q2 2025.
- GeneDx Holdings' 5-year Net Income towards Common Stockholders high stood at $32.7 million for Q3 2021, and its period low was -$308.7 million during Q4 2022.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$29.2 million (2024), whereas its average is -$50.9 million.
- Per our database at Business Quant, GeneDx Holdings' Net Income towards Common Stockholders soared by 15781.33% in 2021 and then crashed by 75905.3% in 2022.
- GeneDx Holdings' Net Income towards Common Stockholders (Quarter) stood at -$40.2 million in 2021, then crashed by 668.23% to -$308.7 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then skyrocketed by 121.1% to $5.4 million in 2024, then plummeted by 240.4% to -$7.6 million in 2025.
- Its Net Income towards Common Stockholders was -$7.6 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$6.5 million in Q1 2025.